Top compounds associated with response to TNXB


Feature Type Standardized
Nominal ANOVA
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC -0.16 0.002
mRNA alvocidib CTRPv2 pan-cancer AAC -0.15 0.002
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.1 0.003
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.12 0.003
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.004
mRNA COL-3 CTRPv2 pan-cancer AAC -0.11 0.004
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.005
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.005
Download CSV